About

CPCC is committed to saving men's lives through early detection of prostate cancer. www.prostatecalif.org

Tags : #MedicalHealth, #Medical&Health

Location :
6709 La Tijera Blvd, Ste 473, Los Angeles, California 90045

Opening Hours

  • Monday 09:00 - 17:00
  • Tuesday 09:00 - 17:00
  • Wednesday 09:00 - 17:00
  • Thursday 09:00 - 17:00
  • Friday 09:00 - 17:00
  • Saturday 09:00 - 17:00
  • Sunday 10:00 - 20:00

Description

The California Prostate Cancer Coalition (CPCC) is a coalition of doctors, prostate cancer survivors (and families), nurses, support groups and others concerned about prostate cancer in California.

Recently diagnosed with prostate cancer or have questions?

Much has been written on the subject of prostate cancer including medical articles, research reports, and feature news articles. These have addressed prostate cancer occurrence among the male populations, research toward a cure, prostate cancer screening, prostate cancer treatment, and prostate cancer survival.

The CPCC site provides resources on all of these prostate cancer considerations. Our goal is help you get the answers to your questions so you can make informed decisions about prostate cancer.

18 Reviews

  • Anynomous
    30 April 2019

    FDA tags Bayer’s prostate cancer drug for priority review as drugmaker gears up against rivals

    report this review
  • Anynomous
    25 April 2019

    PROSPER: A Phase 3, Randomized, Double-blind, Placebo (PBO)-controlled Study of Enzalutamide (ENZA) in Men with Nonmetastatic Castration-Resistant Prostate Cancer (M0 CRPC)

    report this review
  • Anynomous
    25 April 2019

    Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.

    report this review
  • Anynomous
    31 March 2019

    Genetic Variants in HSD3B1 May Predict Outcomes of Prostate Cancer Treated With ADT or Abiraterone

    report this review
  • Anynomous
    02 April 2019

    Current Guidelines Unreliable for Detecting Germline Variants in Prostate Cancer

    report this review
  • Anynomous
    31 March 2019

    AR-V7 in CTCs Tied to Shorter Survival in Certain Patients with Metastatic CRPC

    report this review
  • Anynomous
    28 March 2019

    Chemo Plus Docetaxel Improves Survival, Reduces Metastasis in High-Risk Prostate Cancer

    report this review
  • Anynomous
    26 March 2019

    Genetics of Prostate Cancer (PDQ®)–Health Professional Version

    report this review
  • Anynomous
    21 March 2019

    EAU 2019: Pivotal Study of MRI-Guided Transurethral Ultrasound Ablation in Men with Localized Prostate Cancer: Preliminary Results

    report this review
  • Anynomous
    21 March 2019

    EAU 2019: Development of Novel Criteria for Active Surveillance Based on Multiparametric MRI Alone in Men with Gleason 3+4 Prostate Cancer

    report this review
  • Anynomous
    21 March 2019

    EAU 2019: Potentials of 68Ga-Prostate Specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer

    report this review
  • Anynomous
    18 March 2019

    Testosterone Slows Prostate Cancer Recurrence in Low-Risk Patients

    report this review
  • Anynomous
    18 March 2019

    Hormonal Treatment May Trigger Depression in Men with Prostate Cancer

    report this review
  • Anynomous
    18 March 2019

    Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.

    report this review
  • Anynomous
    18 March 2019

    EAU 2019: The Urologist’s Perspective on Active Surveillance

    report this review
  • Anynomous
    18 March 2019

    EAU 2019: The Medical Oncologist’s Perspective on the Treatment for Prostate Cancer

    report this review
  • Anynomous
    11 March 2019

    The California Prostate Cancer Coalition (CPCC) is proud to partner with UCSF’s Helen Diller Family Comprehensive Cancer Center to present The 2019 Patient Conference on Prostate Cancer, on June 8, 2019, from 8:00 am – 5:00 pm. This conference is a great educational opportunity for patients, families, caregivers, advocates, nurses, health care providers, and all others interested in prostate cancer and how to improve the quality of life for patients!

    Registration is now open!

    report this review
  • Anynomous
    11 March 2019

    Prostate Cancer Risk After Single Negative Biopsy Quantified

    report this review

Rate & Write Reviews